Researchers explain how lymphoma cells metastasise to the brain
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
List view / Grid view
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
We are on the precipice of realising the true potential of genomics studies. Following completion of the Human Genome Project six years ago, huge strides have been made in understanding how the genome works, shedding light on disease pathogenesis and forging therapeutic efforts. In this article, Pushpanathan Muthuirulan explains how…
Having worked in antibody research for over 20 years, Gary McLean has seen how the industry has progressed and understands the potential that antibodies have in the future of medicine. Nikki Withers hears how the focus has shifted from discovery to genetic sequence manipulation and how this can be applied…
Protein therapeutics are a major class of biopharmaceuticals and monoclonal antibodies (mAbs) rule this domain. In this article, Dr Nancy Lopez-Anton outlines the key technologies employed in this important therapeutic discovery area; how they have evolved and what obstacles must be navigated to ensure future success.
New research findings suggest that gut microbiota may regulate lupus flares in pregnant women, presenting a therapeutic target.
Scientists have discovered a molecular pathway that contributes to PAH development, which may lead to a new drug target for the disease.
The UK Biobank, the world’s largest genetics project, will sequence 500,000 genetic samples, which will be available to researchers everywhere.
Using both computational models and stem cell-based experiments, researchers have identified a gene regulator of schizophrenia.
A study on how Polycombs regulate cellular identity could lead to alternative treatments for patients with drug-resistant cancer.
Using mice models in late adolescence, researchers have successfully treated schizophrenia which could help develop therapies for the condition.
This issue includes an investigation into utilising recombinant antibodies for research, a highlight on protein design using computational methods and an examination of the advances in genomic medicine. Also in the issue are articles on next generation sequencing and upstream bioprocessing.
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
The process of Salmonella typhi to damage DNA has been revealed by researchers at the University of Sheffield which could inform treatments.
An animal model to test HIV infection in infants could lead to biomarkers that predict viral rebound after ART interruption.
New gene mutation discovery could lead to more rapid and effective therapies for tuberculosis.